1. Guidance for Industry Nonclinical Studies for the Safety Evaluation of Pharmaceutical Excipients;Food and Drug Administration, Center for Drug Evaluation and Research (CDER),2005
2. CHMP Scientific Article 5(3) Opinion on the Potential Risks of Carcinogens, Mutagens and Substances Toxic to Reproduction when these Substances are Used as Excipients of Medicinal Products for Human Use;European Medicines Agency, Committee for Human Medicinal Products (CHMP),2007
3. Guideline on Excipients in the Dossier for Application for Marketing Authorisation of a Medicinal Product;European Medicines Agency, Committee for Human Medicinal Products (CHMP),2003
4. A new approach to the safety assessment of pharmaceutical excipients: the safety committee of the international pharmaceutical excipients council;Steinberg;Regul. Toxicol. Pharmacol.,1996
5. Polymers for drug delivery systems;Liechty;Ann. Rev. Chem. Biomol. Eng.,2010